Amends GS 115C-375.2 by amending the provision governing the policies adopted by local boards of education regulating when a student with asthma or subject to anaphylactic reactions can possess and self-administer asthma medication to define asthma medication to include epinephrine delivery systems, no longer limiting it to epinephrine auto injectors. Makes conforming changes to refer to the use of "epinephrine delivery systems" instead of "epinephrine auto injectors" in GS 115C-375.2A (concerning school supply of epinephrine delivery systems), GS 115C-218.75 (concerning health and safety standards for charter schools), and GS 115C-238.66 (concerning the supply of epinephrine delivery systems in regional schools). Also amends GS 115C-375.2A to provide that "epinephrine delivery system" includes nasal sprays and injectors with a spring-activated concealed needle. Applies beginning with the 2025-26 school year.
USE OF EPINEPHRINE NASAL SPRAY IN SCHOOLS.
Printer-friendly: Click to view
View NCGA Bill Details | 2025-2026 Session |
AN ACT TO ALLOW THE USE OF EPINEPHRINE NASAL SPRAY IN ADDITION TO AUTO-INJECTORS IN SCHOOLS.Intro. by Lambeth.
Status: Ref to the Com on Health, if favorable, Education - K-12, if favorable, Rules, Calendar, and Operations of the House (House action) (Mar 17 2025)
H 397
Bill Summaries:
-
Bill H 397 (2025-2026)Summary date: Mar 13 2025 - View Summary
View: All Summaries for Bill